Literature DB >> 20974277

Vitamin D(3) signalling to mast cells: A new regulatory axis.

Chunping Yu1, Boris Fedoric, Paul H Anderson, Angel F Lopez, Michele A Grimbaldeston.   

Abstract

Excessive sun exposure or high acute doses of ultraviolet (UV)-B radiation promote cutaneous inflammation and genetic mutations, both of which can ultimately contribute to skin carcinogenesis. A major mediator synthesized in the epidermis in response to UVB irradiation is the secosteroid hormone vitamin D(3), and as such, considerable attention is now turning to the many physiologic processes that it regulates. Recent studies have uncovered an immunoregulatory interaction between vitamin D(3) and dermal mast cells for optimal protection against pathogenic outcomes associated with chronic UVB irradiation of the skin. Most biological effects of vitamin D(3), such as the regulation of transcription in target genes, occur when it binds to its nuclear receptor; however, some actions can also occur via a non-genomic signalling pathway. This review will focus on the relative importance of both pathways in the regulation of vitamin D(3)-mediated UVB protection and will highlight exciting recent findings that point to new research directions. Crown
Copyright © 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20974277     DOI: 10.1016/j.biocel.2010.10.011

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  9 in total

1.  Distribution of bioactive lipid mediators in human skin.

Authors:  Alexandra C Kendall; Suzanne M Pilkington; Karen A Massey; Gary Sassano; Lesley E Rhodes; Anna Nicolaou
Journal:  J Invest Dermatol       Date:  2015-02-10       Impact factor: 8.551

Review 2.  Modulation of the immune system by UV radiation: more than just the effects of vitamin D?

Authors:  Prue H Hart; Shelley Gorman; John J Finlay-Jones
Journal:  Nat Rev Immunol       Date:  2011-08-19       Impact factor: 53.106

3.  The Nedd4-2/Ndfip1 axis is a negative regulator of IgE-mediated mast cell activation.

Authors:  Kwok Ho Yip; Natasha Kolesnikoff; Nicholas Hauschild; Lisa Biggs; Angel F Lopez; Stephen J Galli; Sharad Kumar; Michele A Grimbaldeston
Journal:  Nat Commun       Date:  2016-10-27       Impact factor: 14.919

4.  Low serum 25-hydroxyvitamin D is associated with higher risk of frequent headache in middle-aged and older men.

Authors:  Jyrki K Virtanen; Rashid Giniatullin; Pekka Mäntyselkä; Sari Voutilainen; Tarja Nurmi; Jaakko Mursu; Jussi Kauhanen; Tomi-Pekka Tuomainen
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

5.  Relationship between vitamin D and chronic spontaneous urticaria: a systematic review.

Authors:  Papapit Tuchinda; Kanokvalai Kulthanan; Leena Chularojanamontri; Sittiroj Arunkajohnsak; Sutin Sriussadaporn
Journal:  Clin Transl Allergy       Date:  2018-12-04       Impact factor: 5.871

6.  Possible role of vitamin D3 on the adipocyte/fibroblast trans-differentiation mediated by pancreas cancer

Authors:  S Chirumbolo
Journal:  Curr Health Sci J       Date:  2015-03-15

Review 7.  Mast Cells and Vitamin D Status: A Clinical and Biological Link in the Onset of Allergy and Bone Diseases.

Authors:  Giuseppe Murdaca; Alessandro Allegra; Alessandro Tonacci; Caterina Musolino; Luisa Ricciardi; Sebastiano Gangemi
Journal:  Biomedicines       Date:  2022-08-03

8.  Vitamin D3 Suppresses Class II Invariant Chain Peptide Expression on Activated B-Lymphocytes: A Plausible Mechanism for Downregulation of Acute Inflammatory Conditions.

Authors:  Omar K Danner; Leslie R Matthews; Sharon Francis; Veena N Rao; Cassie P Harvey; Richard P Tobin; Ken L Wilson; Ernest Alema-Mensah; M Karen Newell Rogers; Ed W Childs
Journal:  J Nutr Metab       Date:  2016-05-30

9.  Effects of Serum Vitamin D Levels and Vitamin D Supplementation on Urticaria: A Systematic Review and Meta-Analysis.

Authors:  Yajia Li; Ziqin Cao; Jia Guo; Qiangxiang Li; Juan Su
Journal:  Int J Environ Res Public Health       Date:  2021-05-05       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.